IKPM.JK Ikapharmindo Putramas Tbk.
- Market cap
- IDR 224B
- P/E
- -
- P/B
- -
- ROE
- -13.2%
- Dividend yield
- -
- Fundamental score
- 0.5/5
Ratios use the latest price and the fiscal year ending Dec 2025.
Is IKPM.JK undervalued?
Graham numberThe Graham number of Ikapharmindo Putramas Tbk. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Ikapharmindo Putramas Tbk. fundamental analysis
3 of 21 checks passedROE 0/2
Low return on equity (-13.2%), below 10%.
ROA 0/1
Return on assets (-6.2%) is below the industry median (-0.2%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share history is shorter than 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 0/1
Last year's EPS growth (-674.0%) is below the industry median (-33.3%).
Revenue Growth 0/2
Revenue shrank 3.0% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 1/2
Moderate debt to equity (78.1%), up to 100%.
Debt Trend 0/1
Debt to equity history is shorter than 5 years.
Cash Runway 0/2
Cash runway cannot be calculated.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 0/1
Price to book is negative or not available.
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Ikapharmindo Putramas Tbk. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Ikapharmindo Putramas Tbk.
PT Ikapharmindo Putramas Tbk engages in the research and development, manufacturing, and marketing of pharmaceutical products in Indonesia. It operates through three segments: Non Pharma, Pharma, and Contract Manufacturing. The company offers prescription medicines in various areas, including neurology, psychiatry, dermatology, nephrology, gastroenterology, and nutraceuticals; and pharmaceuticals, vitamins, and over-the-counter products. It also provides hair and baby care p…
Full company profileIkapharmindo Putramas Tbk. financial statements
Ikapharmindo Putramas Tbk. annual financial statements
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | 399B | 441B | 412B | 364B |
| Gross Profit | 181B | 189B | 187B | 149B |
| Operating Income | 34.3B | 32.0B | 18.8B | -23.2B |
| Net Income | 16.6B | 15.3B | 5.01B | -28.8B |
| EPS | 9.84 | 9.10 | 2.98 | -17 |
| Balance Sheet | ||||
| Total Assets | 388B | 463B | 491B | 464B |
| Total Liabilities | 211B | 219B | 245B | 245B |
| Shareholders' Equity | 177B | 245B | 246B | 219B |
| Cash & Short-term Investments | 10.9B | 44.3B | 23.8B | 47.0B |
| Cash Flow | ||||
| Operating Cash Flow | 3.75B | 25.9B | -33.7B | 28.5B |
| Capital Expenditure | 4.86B | 45.2B | 3.65B | 6.02B |
| Ratios | ||||
| ROE | 9.4% | 6.3% | 2.0% | -13.2% |
| ROA | 4.3% | 3.3% | 1.0% | -6.2% |
| Net Profit Margin | 4.2% | 3.5% | 1.2% | -7.9% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Ikapharmindo Putramas Tbk. dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Jun 5, 2024
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | IDR 3.79B | 2.25 | 75.6% |
| 2023 | - | - | - |
| 2022 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Ikapharmindo Putramas Tbk.
- Insiders 80.00%
- Institutions 1.29%
- Public & others 18.71%
- Shares outstanding 1.68B
- Free float 337M
Ikapharmindo Putramas Tbk. company profile
- Company name
- Ikapharmindo Putramas Tbk.
- Ticker
- IKPM.JK
- ISIN
- ID1000199409
- Exchange
- Jakarta Exchange
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Employees
- 1,026
- Fiscal year end
- December
- Address
- Jl. Pulogadung Raya No. 29, Jakarta Timur, Indonesia, 13920
- Phone
- 62 21 460 0086
- Website
- ikapharmindo.com
About Ikapharmindo Putramas Tbk.
PT Ikapharmindo Putramas Tbk engages in the research and development, manufacturing, and marketing of pharmaceutical products in Indonesia. It operates through three segments: Non Pharma, Pharma, and Contract Manufacturing. The company offers prescription medicines in various areas, including neurology, psychiatry, dermatology, nephrology, gastroenterology, and nutraceuticals; and pharmaceuticals, vitamins, and over-the-counter products. It also provides hair and baby care products. PT Ikapharmindo Putramas Tbk was founded in 1978 and is headquartered in Jakarta Timur, Indonesia. PT Ikapharmindo Putramas Tbk is a subsidiary of PT Ikapharma Inti Mas.
Ikapharmindo Putramas Tbk. management
1- Mr. . KartonoPresident Director · born 1968